Julie Saiki became Chief Strategy Officer of Adial Pharmaceuticals on October 28, 2026, per the SEC Form 3 filed October 30, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
Who to call at Adial Pharmaceuticals, and when
A new leader at Adial Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Adial Pharmaceuticals raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Adial Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Adial Pharmaceuticals. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Adial Pharmaceuticals
Location
Glen Allen, Virginia, United States
About
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions and related disorders. The Company's lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients and was recently investigated in the Company's ONWARDTM pivotal Phase 3 clinical trial for the potential treatment of AUD in subjects with certain target genotypes (estimated to be approximately one-third of the AUD population) identified using the Company's companion diagnostic genetic test. ONWARD showed promising results in reducing drinking in heavy drinking patients, and no overt safety or tolerability concerns. AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity. Additional information is available at www.adial.com.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adial Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Glen AllenBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical